WHO's antibacterial pipeline reports

Antibiotics pipeline 'insufficient' to tackle antimicrobial resistance

The World Health Organization's latest "Antibacterial Pipeline Report" shows only 43 antibiotics in clinical development.

Incentivising the Development of New Antibacterial Treatments

The 2023 Progress Report by the Global AMR R&D Hub and WHO addresses the urgent need to incentivise the development of new antibacterial treatments.

The Antibiotic Pipeline - One Health Trust

WHO: 2020 antibacterial agents in clinical and preclinical ... - Carb-X

The clinical pipeline part of the report assesses antibacterial drug candidates in clinical development stages worldwide, including direct-acting small ...

Antimicrobial Resistance Benchmark 2021

GSK reports 16 vaccine projects in its pipeline. It is by far the largest ... such as company annual reports, WHO reports, and clinical trial ...

Confronting antimicrobial resistance 2024 to 2029 - GOV.UK

There are patients in many parts of the world who cannot access the antibiotics and other antimicrobials they need. According to the Access to ...

Antibacterial agents in clinical development: an analysis ... - ReliefWeb

20 SEPTEMBER 2017 | GENEVA - A report, Antibacterial agents in clinical development – an analysis of the antibacterial clinical development ...

Only 12 new antibiotics entered the market in five years, WHO warns ...

The current antibacterial pipeline is woefully insufficient to make a difference in tackling the ongoing threat of antibiotic resistance.” He ...

A novel pre-clinical antibacterial pipeline database | PLOS ONE

To shed light further upstream on the preclinical pipeline the WHO has undertaken a review of the antibacterial preclinical pipeline and ...

An Update on the Clinical Pipelines of New Antibacterial Drugs ...

Among the 17 new antibacterials under clinical trials, there are ten drug candidates that are expected to treat infections caused by the WHO priority pathogens, ...

The State of Innovation in Antibacterial Therapeutics

For a comparison of our pipeline to recent reports from the WHO and the PEW Charitable Trust, see Appendix A4. Page 16. 14. BIO Industry Analysis. Clinical ...

WHO Outlines Antibiotic Development Priorities - Contagion Live

The World Health Organization's new report, “2021 Antibacterial Agents in Clinical and Preclinical Development: An Overview and Analysis,” ...

WHO Report on Antibiotic Pipeline and Online Consultation on ...

The World Health Organization (WHO) has been visibly busy this month in the area of antimicrobial resistance (AMR).

WHO berates 'lack of innovation' when it comes to antibiotic pipeline

The World Health Organization (WHO) has called out Big Pharma for its dearth of antibiotic innovation amid a growing threat of antimicrobial resistance (AMR).

2023 Antibacterial agents in clinical and preclinical development

... Analysis of narrow-spectrum programmes across four consecutive preclinical pipeline reviews. 58. Fig. 19. Analysis of the bacterial spectrum of the total and ...

Antibiotics pipeline is 'insufficient': WHO

The WHO's in-depth analysis of the state of the antibiotic drug pipeline found that currently there are 97 antibacterial agents in development — ...

2019 Antibiotic Resistance Threats Report - CDC

This report underscores the continued threat of antimicrobial resistance in the U.S., the actions taken to combat this threat and gaps slowing ...

WHO report highlights progress and gaps in pipeline of antibiotic ...

The R&D pipeline for new antibiotics is thin and access to new and existing treatments remains a challenge, states the report.

Securing New Drugs for Future Generations - AMR Review

First, antibiotic resistance has been described by the WHO as the single greatest challenge in infectious diseases today, threatening rich and ...

2019 ANTIBACTERIAL AGENTS IN CLINICAL DEVELOPMENT

This report is the WHO's third annual review of the clinical antibacterial pipeline to analyse how the pipeline has responded to the WHO priority pathogens list ...